Skip to main content

Table 2 Clinical Laboratory Determinations

From: Study protocol: rationale and design of the community-based prospective cohort study of kidney function and diabetes in rural New Mexico, the COMPASS study

Screening tests Additional tests in participants with CKD
Complete Blood Cell Count (including Hemoglobin and Hematocrit) Magnesium
Hemoglobin A1C Lead
C-peptide Parathyroid Hormone
Insulin Vitamin D, 25-Hydroxy
Full non-fasting lipid panel  
Renal Function Panel: sodium, potassium, chloride, carbon dioxide, glucose (random/non-fasting), blood urea nitrogen, creatinine, albumin, phosphorus  
Uric Acid  
High Sensitivity C-reactive Protein  
Cystatin C  
Βeta 2 Microglobulin  
Automated Urinalysis Urine Urea Nitrogen
Urine Creatinine Urine Electrolytes: Sodium, Potassium, Chloride, Calcium, Phosphorus, and Magnesium
Urine Albumin and Total Protein Urine Uric Acid